IRCT20210614051574N9招募中2 期
Evaluation of the effect of rivaroxaban treatment in comparison with warfarin on the resolution, size, mobility and morphology of left ventricular apical thrombus and also comparing the incidence of bleeding, readmission, embolic events and cardiovascular events in patients with acute coronary syndrome
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Age over 18 years
- •Acute coronary syndrome
- •Treated with aspirin and Plavix
排除标准
- •Renal and hepatic failure
- •Existence of contraindications to anticoagulant therapy
- •Major trauma
- •Uncontrolled hypertension
研究者
相似试验
招募中
2 期
Assessment of the impact of Rivaroxaban in peripheral artery disease (PAD) of the lower extremitiesIRCT20231117060086N1Ahvaz University of Medical Sciences112
招募中
2 期
Evaluating the efficacy and safety of rivaroxaban comparing to warfarin in patients with chronic thromboembolic pulmonary hypertension (CTEPH) following endartrectomy surgeryChronic Thrombo Embolic Pulmonary Hypertension(CTEPH).Chronic Thromboembolic Pulmonary Hypertension.I27. 24IRCT20151227025726N22Shahid Beheshti University of Medical Sciences96
招募中
3 期
the effect of rivaroxaban on the prevention of deep vein thrombosis in nephrotic syndromephrotic syndrom.Nephrotic syndromeIRCT20220422054617N1Shiraz University of Medical Sciences20
已完成
3 期
Studying the effect of Rivaroxaban 2.5 mg daily on Arteriovenous hemodialysis graft maintenance and thrombosisIRCT20231108059994N1Mashhad University of Medical Sciences78
尚未招募
3 期
Assessment of the effect of rivaroxaban on sudden sensorineural hearing lossIRCT20200708048051N1Rasht University of Medical Sciences140